emergencyBreaking NewsOil Price Dip Below $100 Rescues US Equity Markets From Inflation FearsHarrison Ford's $4,640 Social Security Check Caps the Value of Lifetime EarningsEarning $117,000 at 51 Doesn’t Make You Upper Middle Class — Your Net Worth DoesQuantoz launches pound and złoty stablecoins, creating Europe’s first five-token regulated networkEasing Oil Prices Lower Inflation Pressure on Federal Reserve PolicyOil Price Dip Below $100 Rescues US Equity Markets From Inflation FearsHarrison Ford's $4,640 Social Security Check Caps the Value of Lifetime EarningsEarning $117,000 at 51 Doesn’t Make You Upper Middle Class — Your Net Worth DoesQuantoz launches pound and złoty stablecoins, creating Europe’s first five-token regulated networkEasing Oil Prices Lower Inflation Pressure on Federal Reserve Policy
DoiDoi
Credit & Lendingexpand_more
Credit CardsPersonal LoansStudent Loans
Markets & Investingexpand_more
Stocks & ETFsCrypto & BlockchainFed & Macro
Retirement & Benefitsexpand_more
401(k) & IRASocial SecurityRetirement Policy
Real Estateexpand_more
Mortgage RatesHousing Market
Financial Foundationexpand_more
Budgeting & SavingInsurance
Latest News
MarketsPortfolio
The Digital Ledger
Credit & Lending
Markets & Investing
Retirement & Benefits
Real Estate
Financial Foundation
Latest News
Dashboards

Institutional Financial Analysis

Home/Markets & Investing/CATHIE WOOD

ARK Invest reduces its stake in Strata Critical Medical as analysts predict 120% upside

RV

Remy Villiers

Cathie Wood · Apr 14, 2026

ARK Invest reduces its stake in Strata Critical Medical as analysts predict 120% upside

Source: DojiDoji Data Terminal

ARK Invest ETFs sold 182,767 shares of Strata Critical Medical (SRTA) on April 13, totaling a combined value of $738,378. This sale follows a sale of more than 75,000 shares on April 10. The shares were sold through the ARK Autonomous Technology & Robotics ETF (ARKQ) and the ARK Space Exploration & Innovation ETF (ARKX).

Related Brief1h ago
thematic investing

Cathie Wood’s Sell-Off in SRTA Reflects a Bet Against Traditional Medical Devices in an AI-Driven Future

Cathie Wood sold 180,000 shares of Strata Critical Medical (SRTA.US) on April 13. SRTA manufactures traditional intensive care medical devices. Traditional ICU devices lack data-driven capabilities. Without data collection capacity, medical devices cannot integrate with generative AI systems. Cathie Wood envisions medical devices as data terminals for large-scale AI models. Devices that cannot feed AI models have diminished development potential in Wood’s investment framework. SRTA’s exclusion from AI synergy reduces its long-term growth outlook in ARK Invest’s portfolio strategy.

B. Riley analyst Yuan Zhi initiated coverage of the company with a Buy rating and an $8 price target, citing the company's position as the only end-to-end platform in organ transplant logistics. Craig-Hallum analyst Bill Bonello also initiated coverage with a Buy rating and an $8 price target.

Related Brief2d ago
portfolio rotation

ARK Invest Rotates Capital From Medical Hardware Into Genomic Data and Cloud Infrastructure

ARK Invest's portfolio risk exposure is now more sensitive to cloud buildouts, power availability, and the economics of scaling data centers. This shift follows a rotation toward data center capacity, precision medicine, and next-generation energy. On April 9, Cathie Wood sold 57,700 shares of Strata Critical Medical and 3,478 shares of BWX Technologies. The divestment from Strata Critical Medical follows a pattern of selling medical device companies that lack software and algorithm functionality. ARK Invest also reduced holdings in select semiconductor and internet names to fund purchases of 32,800 shares of GeneDx Holdings, a company that stores genomic data of rare diseases and pediatric illnesses, and 3,447 shares of Arcturus Therapeutics. The firm also bought $11 million of a megacap tech stock as part of a repositioning around compute, networking, and cloud capacity.

Wall Street has a Strong Buy consensus rating on the stock based on three unanimous Buy recommendations. Based on an average price target of $9.08, analysts see over 120% upside from the current share price of $4.12.

Related Brief1d ago
portfolio rotation

ARK Invest Shifts AI Hardware Profits Into Government AI Software

Liquidity for ARK Invest was secured through the sale of 44,400 shares of Advanced Micro Devices. The fund used these funds to increase its holdings in Palantir. The U.S. military uses Palantir's Maven Intelligence Platform to identify targets in the Middle East. More than half of Palantir's U.S. revenue comes from the government, including the Department of Defense and U.S. Immigration and Customs Enforcement. These government contracts provide the company with earnings visibility.

Cathie Wood

The Ledger Morning

The essential intelligence to start your trading day. Delivered 6:00 AM EST.

Join 50,000+ professionals who start their day with The Digital Ledger.

No spam. Unsubscribe anytime.

Read More Analysis

Fed interest rate decision

Gold climbs as diplomacy tempers geopolitical risk, shifting bullion’s price driver from safe-haven flows to policy expectations

Gold climbed 0.7% to $4,773.26 per ounce Tuesday as diplomatic overtures between the U.S. and Iran reshaped the forces d…

SEC ESG enforcement

Social Security’s insolvency date moves up as policy cuts revenue and shrinks workforce

A typical couple turning 60 in 2025 could lose $18,400 a year in Social Security benefits if lawmakers fail to act. The …

DoiDoi

© 2026 DojiDoji. All rights reserved.

EditorialEditorial GuidelinesCorrections
LegalPrivacy PolicyTerms of Service
DisclosureSEC DisclosuresAd Choice
SocialX (Twitter)LinkedIn